Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Small Pharma Inc. DMTTF OTC

Other OTC • Healthcare • Biotechnology • GB • USD

SharesGrow Score
40/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Small Pharma Inc. (DMTTF) is a Biotechnology company in the Healthcare sector, currently trading at $0.11. It has a SharesGrow Score of 37/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Net income is $23M (loss), growing at -109.5%/yr. Net profit margin is 0% (thin). Gross margin is 100% (+0 pp trend).

Balance sheet: total debt is $609,553 against $17M equity (Debt-to-Equity (D/E) ratio 0.04, conservative). Current ratio is 5.77 (strong liquidity). Debt-to-assets is 2.9%. Total assets: $21M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 100/100 (Pass), Moat 46/100 (Partial), Future ?/100 (Fail), Income ?/100 (Fail).

DMTTF SharesGrow Score Overview

54/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 46/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — DMTTF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
DMTTF: -100%/yr revenue is, -109.5%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
100/100
Balance sheet DMTTF: Debt-to-Equity (D/E) ratio 0.04 (conservative), Current ratio is 5.77 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
46/100
DMTTF: Gross margin is 100% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 46/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.045-0.1905
Volume108.7K
Avg Volume (30D)109.35K
Market Cap$37.51M
Beta (1Y)0.86
Share Statistics
EPS (TTM)-0.07
Shares Outstanding$321.47M
IPO Date2021-06-07
CEOGeorge Tziras
Financial Highlights & Ratios
EBITDA$-24.63M
Net Income$-22.84M
Operating Income$-24.68M
Total Cash$18.54M
Total Debt$609.55K
Net Debt$-17.93M
Total Assets$20.98M
Price / Earnings (P/E)-1.6
Analyst Forecast
Company Info
CountryGB
ExchangeOther OTC
CurrencyUSD

Price Chart

Track all markets on TradingView
DMTTF
Small Pharma Inc. ↗  ·  Other OTC
Healthcare • Biotechnology
0.05 52WK RANGE 0.19

People Also View

CMVLF
CMVLF
Cellectis S.A.
$3.08
-30.00%
 CVALF
CVALF
Covalon Technologies Ltd.
$1.44
-0.69%
 BITRF
BITRF
Biotron Limited
$0.03
+0.00%
 RVXCF
RVXCF
Resverlogix Corp.
$0.08
-1.14%
 CRPOF
CRPOF
Ceapro Inc.
$0.17
-13.04%
 CPMV
CPMV
Mosaic ImmunoEngineering Inc.
$0.70
+0.00%
 BIOAF
BIOAF
Bioasis Technologies Inc.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message